department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Lexeo Therapeutics, Inc. ($LXEO) · pharmadog

PUBLIC COMPANY

$LXEOLexeo Therapeutics, Inc.

New York, NY, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

3

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

3Phase 2

Alzheimer's Disease

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Lexeo Therapeutics, Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$LXEO

SEC CIK

0001907108

country

US

source

sec_tickers

top tags

Cardiology2 Alzheimer's Disease1

mentioned in

0news items

entity-linker matched

$LXEO

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 13m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Insider activity

source: SEC Form 4

open-market buys + sells

Apr 6, 26SELLTownsend Richard Nolan· Chief Executive Officer55,000 sh @ $5.69−$313K↗
Feb 18, 26SELLTownsend Richard Nolan· Chief Executive Officer10,173 sh @ $6.38−$65K↗
Feb 18, 26SELLOtero Jose Manuel· Chief Operating Officer3,016 sh @ $6.40−$19K↗

routine RSU / option mechanics (6)

Mar 13, 26grantOtero Jose Manuel · Chief Operating Officer5,930 sh
Mar 13, 26grantTownsend Richard Nolan · Chief Executive Officer2,623 sh
Feb 13, 26grantBhalla Narinder Pal · Chief Medical Officer297,000 sh
Feb 13, 26grantBhalla Narinder Pal · Chief Medical Officer49,500 sh
Feb 4, 26grantTownsend Richard Nolan · Chief Executive Officer161,665 sh

Feb 4, 26

grant

Townsend Richard Nolan · Chief Executive Officer

646,665 sh

Active trials

—Clinical Course Of Disease In Participants With FA-CMrecruitingn=65
phase2Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxiaactive not recruitingn=8
—Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variantenrolling by invitationn=10
phase2Gene Therapy for ACM Due to a PKP2 Pathogenic Variantactive not recruitingn=10
phase2Gene Therapy for APOE4 Homozygote of Alzheimer's Diseasecompletedn=15
phase1Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Diseaseactive not recruitingn=10
—A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACMrecruitingn=40